Safety Shot announced that a clinical trial to measure the effects of Safety Shot on blood and breath alcohol has commenced. Safety Shot is the first patented beverage that helps people feel better faster by reducing blood alcohol content and boosting clarity. Created by industry experts and validated by research, Safety Shot is a nutraceutical functional beverage that accelerates the body’s break-down of alcohol while aiding in recovery and rehydration. While there are many anecdotal studies that demonstrate Safety Shot can rapidly reduce blood alcohol content and the effects of alcohol, a double-blinded placebo-controlled clinical trial in 36 participants has been initiated. This controlled study will measure the amount of alcohol in the blood and breath, together with indices of alcohol effects. Safety Shot will be available for retail purchase at www.DrinkSafetyShot.com and www.Amazon.com in December 2023. The Company plans to launch business-to-business sales of Safety Shot to distributors, retailers, restaurants, and bars in the first quarter of 2024.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on SHOT:
- Safety Shot Continues Scientific Development with Double-Blind Placebo-Controlled Trial Designed to Assess the Effects of Safety Shot on Blood and Breath Alcohol Levels
- Safety Shot files to sell 1.98M shares of common stock for holders
- Safety Shot says preparing lawsuit against short sellers
- Safety Shot issues warning to its shareholders.
- Capybara Research short Safety Shot, questions products legitimacy